Supernus Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8684591089
USD
47.76
-3.06 (-6.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
211.57
192.10
165.45
149.82
174.16
175.69
168.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
211.57
192.10
165.45
149.82
174.16
175.69
168.32
Raw Material Cost
48.02
43.79
38.15
36.15
44.94
37.67
38.62
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
126.49
180.48
94.55
89.94
81.61
69.75
85.90
Other Expenses
2.73
2.89
2.16
2.63
2.80
2.84
2.56
Total Expenditure (Excl Depreciation)
201.85
253.13
154.31
152.42
154.60
135.86
150.11
Operating Profit (PBDIT) excl Other Income
9.7
-61
11.100000000000001
-2.6
19.6
39.8
18.2
Other Income
2.02
2.28
4.53
4.42
4.98
4.10
3.73
Operating Profit (PBDIT)
36.76
-33.93
36.99
22.21
43.38
64.02
42.66
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-13.66
0.80
1.00
-7.66
1.84
1.02
4.36
Gross Profit (PBDT)
163.55
148.31
127.31
113.68
129.22
138.02
129.70
Depreciation
25.02
24.82
21.32
20.38
18.84
20.09
20.71
Profit Before Tax
-1.91
-57.95
16.67
-5.83
26.38
44.94
26.30
Tax
2.19
-12.84
-5.83
6.00
11.05
6.45
6.39
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-4.11
-45.12
22.50
-11.83
15.33
38.50
19.92
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-4.11
-45.12
22.50
-11.83
15.33
38.50
19.92
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-4.11
-45.12
22.50
-11.83
15.33
38.50
19.92
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,061.71
1,049.67
1,063.90
1,030.70
1,035.73
1,007.15
957.45
Earnings per share (EPS)
-0.07
-0.8
0.4
-0.21
0.27
0.69
0.36
Diluted Earnings per share
-0.07
-0.8
0.4
-0.21
0.27
0.69
0.36
Operating Profit Margin (Excl OI)
4.6%
-31.77%
6.73%
-1.73%
11.23%
22.67%
10.82%
Gross Profit Margin
10.92%
-17.25%
22.96%
9.71%
25.97%
37.01%
27.93%
PAT Margin
-1.94%
-23.49%
13.6%
-7.89%
8.8%
21.91%
11.83%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 10.15% vs 16.07% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 90.91% vs -300.44% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 195.86% vs -211.38% in Sep 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Supernus Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
211.57
6.16
205.41
3,334.58%
Other Operating Income
0.00
0.00
0.00
Total Operating income
211.57
6.16
205.41
3,334.58%
Raw Material Cost
48.02
2.07
45.95
2,219.81%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
126.49
53.70
72.79
135.55%
Other Expenses
2.73
8.41
-5.68
-67.54%
Total Expenditure (Excl Depreciation)
201.85
139.83
62.02
44.35%
Operating Profit (PBDIT) excl Other Income
9.72
-133.67
143.39
107.27%
Other Income
2.02
11.03
-9.01
-81.69%
Operating Profit (PBDIT)
36.76
-121.64
158.40
130.22%
Interest
0.00
0.00
0.00
Exceptional Items
-13.66
0.00
-13.66
Gross Profit (PBDT)
163.55
4.09
159.46
3,898.78%
Depreciation
25.02
0.99
24.03
2,427.27%
Profit Before Tax
-1.91
-122.64
120.73
98.44%
Tax
2.19
0.18
2.01
1,116.67%
Provisions and contingencies
0
0
0.00
Profit After Tax
-4.11
-122.81
118.70
96.65%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-4.11
-122.81
118.70
96.65%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-4.11
-122.81
118.70
96.65%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,061.71
992.08
69.63
7.02%
Earnings per share (EPS)
-0.07
-1.29
1.22
94.57%
Diluted Earnings per share
-0.07
-1.29
1.22
94.57%
Operating Profit Margin (Excl OI)
4.60%
-2,169.55%
0.00
2,174.15%
Gross Profit Margin
10.92%
-1,974.37%
0.00
1,985.29%
PAT Margin
-1.94%
-1,993.43%
0.00
1,991.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 21.16 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 10.15% vs 16.07% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 21.47% vs 6.03% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit -0.41 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 90.91% vs -300.44% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -126.80% vs 1,175.00% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.47 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 195.86% vs -211.38% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -9.64% vs -5.65% in Dec 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.60%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024